Study of MG-K10 Humanized Monoclonal Antibody Injection in Patients With Atopic Dermatitis

Clinical trial NCT06026891 · UNKNOWN

Trial details

NCT number: NCT06026891
Sponsor: Shanghai Mabgeek Biotech.Co.Ltd
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Atopic Dermatitis

Start date: 2024-01-13
Primary completion: 2025-06-11
Enrollment: 498

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.